Elevated coronary calcium scores are associated with higher residual platelet aggregation after clopidogrel treatment in patients with stable angina pectoris

International Journal of Cardiology

Volumn 135, Issue 1, 2009, Pages 132-135

  Burgstahler, Christof ^a   Geisler, Tobias ^a   Lindemann, Stephan ^a   Brodoefel, Harald ^a   Reimann, Anja ^a   Heuschmid, Martin ^a   Gawaz, Meinrad ^a   Schroeder, Stephen ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Agatston score; Calcium scoring; Clopidogrel; Coronary artery disease; Platelets; Risk

Indexed keywords

CALCIUM; CLOPIDOGREL;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY STENT; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESIDUE ANALYSIS; SCORING SYSTEM; STABLE ANGINA PECTORIS; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; CALCIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 67349200376     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.02.020     Document Type: Article

References (24)

1. Folsom A.R., Evans G.W., Carr J.J., and Stillman A.E. Association of traditional and nontraditional cardiovascular risk factors with coronary artery calcification. Angiology 55 (2004) 613-623
2. Raggi P., Shaw L.J., Berman D.S., and Callister T.Q. Gender-based differences in the prognostic value of coronary calcification. J Womens Health (Larchmt) 13 (2004) 273-283
3. Raggi P., Shaw L.J., Berman D.S., and Callister T.Q. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 43 (2004) 1663-1669
4. Raggi P., Cooil B., Shaw L.J., et al. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol 92 (2003) 827-829
5. Shaw L.J., Raggi P., Schisterman E., Berman D.S., and Callister T.Q. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 228 (2003) 826-833
6. Pletcher M.J., Tice J.A., Pignone M., McCulloch C., Callister T.Q., and Browner W.S. What does my patient's coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease risk. BMC Med 2 (2004) 31
7. Arad Y., Goodman K.J., Roth M., Newstein D., and Guerci A.D. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 46 (2005) 158-165
8. Raggi P., Callister T.Q., Cooil B., et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 101 (2000) 850-855
9. Arad Y., Goodman K.J., Roth M., Newstein D., and Guerci A.D. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 46 (2005) 158-165
10. O'Malley P.G., Taylor A.J., Jackson J.L., Doherty T.M., and Detrano R.C. Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol 85 (2000) 945-948
11. Arad Y., Spadaro L.A., Goodman K., Newstein D., and Guerci A.D. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 36 (2000) 1253-1260
12. Park R., Detrano R., Xiang M., et al. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 106 (2002) 2073-2077
13. Vliegenthart R., Oudkerk M., Song B., van der Kuip D.A., Hofman A., and Witteman J.C. Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. Eur Heart J 23 (2002) 1596-1603
14. Wong N.D., Hsu J.C., Detrano R.C., Diamond G., Eisenberg H., and Gardin J.M. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 86 (2000) 495-498
15. Kondos G.T., Hoff J.A., Sevrukov A., et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107 (2003) 2571-2576
16. Taylor A.J., Bindeman J., Feuerstein I., Cao F., Brazaitis M., and O'Malley P.G. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol 46 (2005) 807-814
17. Greenland P., LaBree L., Azen S.P., Doherty T.M., and Detrano R.C. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291 (2004) 210-215
18. Geisler T., Langer H., Wydymus M., et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 27 (2006) 2420-2425
19. Hochholzer W., Trenk D., Frundi D., et al. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation 111 (2005) 2560-2564
20. Feher G., Koltai K., Alkonyi B., et al. Clopidogrel resistance: role of body mass and concomitant medications. Int J Cardiol 120 (2007) 188-192
21. Barsky A.A., and Arora R.R. Clopidogrel resistance: myth or reality?. J Cardiovasc Pharmacol Ther 11 (2006) 47-53
22. Matetzky S., Shenkman B., Guetta V., et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109 (2004) 3171-3175
23. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., et al. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res 115 (2005) 101-108
24. Angiolillo D.J., Shoemaker S.B., Desai B., et al. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study. Circulation 115 (2007) 708-716